United States Nuclear Regulatory Commission - Protecting People and the Environment

ACMUI Charter

United States Nuclear Regulatory Commission Charter for the Advisory Committee on Medical Uses of Isotopes

1. Committee's Official Designation:

Advisory Committee on the Medical Uses of Isotopes

2. Authority:

Established Pursuant to Section 9 of Public Law 92-463 as an NRC discretionary committee.

3. Committee's objectives, scope of activities and duties are as follows:

The Committee provides advice, as requested by the Director, Division of Materials Safety and State Agreements (MSSA), Office of Federal and State Materials and Environmental Management Programs (FSME), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy. The Committee may provide consulting services as requested by the Director, MSSA.

4. Official to whom this Committee reports:

Director, Division of Materials Safety and State Agreements
Office of Federal and State Materials and Environmental Management Programs
U.S. Nuclear Regulatory Commission
Washington, DC 20555

5. Agency responsible for providing necessary support to this Committee:

U.S. Nuclear Regulatory Commission.

6. Estimated Annual Operating Costs and Staff Years:

Approximately 13 members utilize 2.1 FTE (includes approximately 1.2 FTE for NRC staff and .9 FTE for ACMUI member compensation and travel) and $318,000.

7. Designated Federal Officer:

A full time NRC employee from the Division of Materials Safety and State Agreements will serve as the Designated Federal Officer.

8. Estimated number of meetings per year:

Five meetings per year, three of which are teleconferences.

9. Duration:

Continuing Committee

10. The Committee’s termination date:

Continuing Committee subject to Charter renewal in March 2016.

11. Membership and Designation:

Members are appointed by the Director, FSME as Special Government Employees (SGEs). The membership includes health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy.

12. Filing date:

March 14, 2014

 

Andrew L. Bates
Advisory Committee Management Officer
Office of the Secretary of the Commission

Page Last Reviewed/Updated Tuesday, March 25, 2014